TY - JOUR
T1 - Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions
T2 - a consensus document from European cardiologists, gynaecologists, and endocrinologists
AU - Maas, Angela H.E.M.
AU - Rosano, Giuseppe
AU - Cifkova, Renata
AU - Chieffo, Alaide
AU - van Dijken, Dorenda
AU - Hamoda, Haitham
AU - Kunadian, Vijay
AU - Laan, Ellen
AU - Lambrinoudaki, Irene
AU - Maclaran, Kate
AU - Panay, Nick
AU - Stevenson, John C.
AU - van Trotsenburg, Mick
AU - Collins, Peter
N1 - Publisher Copyright:
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.
PY - 2021/3/7
Y1 - 2021/3/7
N2 - Women undergo important changes in sex hormones throughout their lifetime that can impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors dominate in older age, there are several female-specific risk factors and inflammatory risk variables that influence a woman's risk at younger and middle age. Hypertensive pregnancy disorders and gestational diabetes are associated with a higher risk in younger women. Menopause transition has an additional adverse effect to ageing that may demand specific attention to ensure optimal cardiovascular risk profile and quality of life. In this position paper, we provide an update of gynaecological and obstetric conditions that interact with cardiovascular risk in women. Practice points for clinical use are given according to the latest standards from various related disciplines (Figure 1).
AB - Women undergo important changes in sex hormones throughout their lifetime that can impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors dominate in older age, there are several female-specific risk factors and inflammatory risk variables that influence a woman's risk at younger and middle age. Hypertensive pregnancy disorders and gestational diabetes are associated with a higher risk in younger women. Menopause transition has an additional adverse effect to ageing that may demand specific attention to ensure optimal cardiovascular risk profile and quality of life. In this position paper, we provide an update of gynaecological and obstetric conditions that interact with cardiovascular risk in women. Practice points for clinical use are given according to the latest standards from various related disciplines (Figure 1).
KW - Coronary artery disease
KW - Female-specific risk factors
KW - Hypertensive pregnancy disorders
KW - Ischaemic heart disease
KW - Menopausal hormone therapy
KW - Menopause
KW - Sexual health women
KW - Transgender
UR - http://www.scopus.com/inward/record.url?scp=85102906230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102906230&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehaa1044
DO - 10.1093/eurheartj/ehaa1044
M3 - Article
C2 - 33495787
AN - SCOPUS:85102906230
VL - 42
SP - 967
EP - 984
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 10
ER -